ADE

Nov 07, 2019

Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting

Jul 18, 2019

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

Dec 03, 2018

Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Sep 11, 2018

Jazz Pharmaceuticals Announces an Informational Webcast for Investors Related to Vyxeos EU Launch

Jul 11, 2018

BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia

Jun 29, 2018

Vyxeos(TM) Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

Feb 08, 2018

National Comprehensive Cancer Network® adds Jazz Pharmaceuticals' Vyxeos(TM) (daunorubicin and cytarabine) Liposome for Injection to Clinical Practice Guidelines in Oncology

Dec 14, 2017

BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

Jun 15, 2017

Tolero Pharmaceuticals to Present Supportive Preclinical Data for Investigational CDK Inhibitor Alvocidib at European Hematology Association Annual Meeting